{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:42:59Z","timestamp":1790116979069,"version":"4.0.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Statins are competitive inhibitors of 3-hydroxy-3methylglutaryl coenzyme A reductase (HMG-CoA reductase) that catalyses HMG-CoA conversion to mevalonate, a process involved in synthesizing cholesterol in humans and ergosterol in fungi. The effect of statin use on the risk of development of invasive aspergillosis (IA) in lung transplant recipients (LTRs) is not well documented.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective study included LTRs from 2010 to 2017 who were followed for one-year post-transplant. Proven or probable IA was diagnosed as per ISHLT criteria. We performed a multivariable Cox proportional hazards model of the association between IA and statin use (minimum of 2 weeks duration prior to IA), adjusting for other known IA risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 785 LTRs, 44% female, mean age 53 years old, the most common underlying disease being pulmonary fibrosis (23.8%). In total, 451 LTRs (57%) received statins post-transplant, atorvastatin was the most commonly used statin (68%). The mean duration of statins post-transplant was 347 days (interquartile range [IQR]: 305 to 346). And 55 (7%) LTRs developed IA in the first-year post-transplant. Out of these 55 LTRs, 9 (16.3%) had received statin before developing IA. In multivariable analysis, statin use was independently associated with a lower risk of IA (P = .002, SHR 0.30, 95% confidence interval [CI] 95% .14\u2013.64). Statin use was also associated with a lower incidence of post-transplant Aspergillus colonization, 114 (34%) in the no statin group vs 123 (27%) in the statin group (P = .038).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The use of statin for a minimum of two weeks during the first-year post-transplant was associated with a 70% risk reduction of IA in LTRs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciac551","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T15:16:49Z","timestamp":1659021409000},"page":"e1379-e1384","source":"Crossref","is-referenced-by-count":15,"title":["Statin Use May Be Associated With a Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients"],"prefix":"10.1093","volume":"76","author":[{"given":"Armelle P\u00e9rez-Cort\u00e9s","family":"Villalobos","sequence":"first","affiliation":[{"name":"Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"},{"name":"Department of Medicine, University of Manitoba , Winnipeg, Manitoba , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Foroutan","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Davoudi","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Kothari","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Martinu","sequence":"additional","affiliation":[{"name":"Lung Transplant Program, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne G","family":"Singer","sequence":"additional","affiliation":[{"name":"Lung Transplant Program, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[{"name":"Lung Transplant Program, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Husain","sequence":"additional","affiliation":[{"name":"Transplant Infectious Diseases, Multi-Organ Transplant Program, University Health Network , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"2023020817083723000_ciac551-B1","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2023020817083723000_ciac551-B2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1469-0691.2005.01128.x","article-title":"Valencia lung transplant G. Aspergillus infections in lung transplant recipients: risk factors and outcome","volume":"11","author":"Sole","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"2023020817083723000_ciac551-B3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: Incidence and prognosis","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023020817083723000_ciac551-B4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J Infect"},{"issue":"107483","key":"2023020817083723000_ciac551-B5","doi-asserted-by":"publisher","first-page":"107483","DOI":"10.1016\/j.pharmthera.2020.107483","article-title":"Antifungal effects of statins","volume":"208","author":"Tavakkoli","year":"2020","journal-title":"Pharmacol Ther"},{"key":"2023020817083723000_ciac551-B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5495\/wjcid.v1.i1.4","article-title":"Statins as antifungal agents","volume":"1","author":"Galg\u00f3czy","year":"2011","journal-title":"World J Clin Infect Dis"},{"key":"2023020817083723000_ciac551-B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","article-title":"Growth inhibition of Candida species and Aspergillus fumigatus by statins","volume":"262","author":"Macreadie","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"2023020817083723000_ciac551-B8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2023020817083723000_ciac551-B9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/rccm.200205-410OC","article-title":"Statin use is associated with improved function and survival of lung allografts","volume":"167","author":"Johnson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5208","key":"2023020817083723000_ciac551-B10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1126\/science.7716512","article-title":"Protein lipidation in cell signaling","volume":"268","author":"Casey","year":"1995","journal-title":"Science"},{"key":"2023020817083723000_ciac551-B11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1128\/AAC.41.4.850","article-title":"In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans","volume":"41","author":"Chin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2023020817083723000_ciac551-B12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/13693780701397673","article-title":"Antifungal activity of statins against Aspergillus species","volume":"45","author":"Qiao","year":"2007","journal-title":"Med Mycol"},{"key":"2023020817083723000_ciac551-B13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/597039","article-title":"Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2023020817083723000_ciac551-B14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopha.2018.12.076","article-title":"Are the statins promising antifungal agents against invasive candidiasis?","volume":"111","author":"Lima","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2023020817083723000_ciac551-B15","first-page":"33","article-title":"Effect of different statins on the antifungal activity of polyene antimycotics","volume":"54","author":"Nyilasi","year":"2010","journal-title":"Acta Biol Szeged"},{"key":"2023020817083723000_ciac551-B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"2023020817083723000_ciac551-B17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1099\/jmm.013946-0","article-title":"In vitro interactions between primycin and different statins in their effects against some clinically important fungi","volume":"59","author":"Nyilasi","year":"2010","journal-title":"J Med Microbiol"},{"key":"2023020817083723000_ciac551-B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1590\/s0036-46652012000400003","article-title":"In vitro synergism of simvastatin and fluconazole against Candida species","volume":"54","author":"Menezes","year":"2012","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"2023020817083723000_ciac551-B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijfoodmicro.2018.11.012","article-title":"Antifungal activity of silver nanoparticles and simvastatin against toxigenic species of Aspergillus","volume":"291","author":"Bocate","year":"2019","journal-title":"Int J Food Microbiol"},{"key":"2023020817083723000_ciac551-B20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2023020817083723000_ciac551-B21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in sensitized lung transplant recipients with perioperative desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"},{"key":"2023020817083723000_ciac551-B22","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.healun.2018.02.006","article-title":"A strategy for prevention of fungal infections in lung transplantation: role of bronchoalveolar lavage fluid galactomannan and fungal culture","volume":"37","author":"Husain","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2023020817083723000_ciac551-B23","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transplant"},{"key":"2023020817083723000_ciac551-B24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3109\/00365548.2012.691207","article-title":"Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients","volume":"44","author":"Tofte","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"2023020817083723000_ciac551-B25","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1111\/j.1600-6143.2009.02734.x","article-title":"Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness","volume":"9","author":"Cadena","year":"2009","journal-title":"Am J Transplant"},{"key":"2023020817083723000_ciac551-B26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transplant"},{"key":"2023020817083723000_ciac551-B27","doi-asserted-by":"publisher","first-page":"e77317","DOI":"10.1371\/journal.pone.0077317","article-title":"Effect of statin use on outcomes of adults with candidemia","volume":"8","author":"Cuervo","year":"2013","journal-title":"PLoS One"},{"key":"2023020817083723000_ciac551-B28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s10096-009-0787-4","article-title":"Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients","volume":"28","author":"Hsu","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2023020817083723000_ciac551-B29","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1111\/j.1439-0507.2010.01957.x","article-title":"Case-control study of statin prevention of mould infections","volume":"54","author":"Thompson","year":"2011","journal-title":"Mycoses"},{"key":"2023020817083723000_ciac551-B30","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transplant"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac551\/45184074\/ciac551.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e1379\/49125263\/ciac551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/76\/3\/e1379\/49125263\/ciac551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T17:46:36Z","timestamp":1675878396000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/76\/3\/e1379\/6651155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,7,28]]},"published-print":{"date-parts":[[2023,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac551","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,7,28]]}}}